Abstract:The prevalence of diabetes has been accelerating at an alarming rate in the last decade; some describe it as an epidemic. Diabetic eye complications are the leading cause of blindness in adults aged 25-74 in the United States. Early diagnosis and development of effective preventatives and treatments of diabetic retinopathy are essential to save sight. We describe efforts to establish functional indicators of retinal health and predictors of diabetic retinopathy. These indicators and predictors will be needed as markers of the efficacy of new therapies. Clinical trials aimed at either prevention or early treatments will rely heavily on the discovery of sensitive methods to identify patients and retinal locations at risk, as well as to evaluate treatment effects. We report on recent success in revealing local functional changes of the retina with the multifocal electroretinogram (mfERG). This objective measure allows the simultaneous recording of responses from over 100 small retinal patches across the central 45 degrees field. We describe the sensitivity of mfERG implicit time measurement for revealing functional alterations of the retina in diabetes, the local correspondence between functional (mfERG) and structural (vascular) abnormalities in eyes with early nonproliferative retinopathy, and longitudinal studies to formulate models to predict the retinal sites of future retinopathic signs. A multivariate model including mfERG implicit time delays and 'person' risk factors achieved 86% sensitivity and 84% specificity for prediction of new retinopathy development over one year at specific locations in eyes with some retinopathy at baseline. A preliminary test of the model yielded very positive results. This model appears to be the first to predict, quantitatively, the retinal locations of new nonproliferative diabetic retinopathy development over a one-year period. In a separate study, the predictive power of a model was assessed over one- and two-year follow-ups. This permitted successful prediction of new retinopathy development in eyes with and without retinopathy at baseline. Finally, we briefly describe our current research efforts to (a) locally predict future sight-threatening diabetic macular edema, (b) investigate local retinal function change in adolescent patients with diabetes, and (c) better understand the physiological bases of the mfERG delays. The ability to predict the retinal locations of future retinopathy based on mfERG implicit time provides clinicians a powerful tool to screen, follow-up, and even consider early prophylactic treatment of the retinal tissue in diabetic patients. It also aids identification of 'at risk' populations for clinical trials of candidate therapies, which may greatly reduce their cost by decreasing the size of the needed sample and the duration of the trial.

Multifocal Electroretinogram and Short-Wavelength Automated Perimetry Measures in Diabetic Eyes with Little or No Retinopathy.

Retinal Function in Normal and Diabetic Eyes Mapped with the Slow Flash Multifocal Electroretinogram.

Comparison of Mferg Waveform Components and Implicit Time Measurement Techniques for Detecting Functional Change in Early Diabetic Eye Disease

Local Multifocal Oscillatory Potential Abnormalities in Diabetes and Early Diabetic Retinopathy.

Multifocal Electroretinogram Delays Predict Sites of Subsequent Diabetic Retinopathy.

A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Multifocal Electroretinogram Can Detect the Abnormal Retinal Change in Early Stage of type2 DM Patients without Apparent Diabetic Retinopathy

Discriminating early-stage diabetic retinopathy with subjective and objective perimetry

Association Between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes.

Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression

Using Multifocal ERG Responses to Discriminate Diabetic Retinopathy.

The Multifocal ERG in Early Detection of Diabetic Retinopathy.

Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema

Assessment of functional changes in long‐standing type 1 diabetic patients without diabetic retinopathy with multifocal electroretinogram

Evaluation of optical coherence tomography angiography and pattern and flash electroretinography in diabetes mellitus without retinopathy

Visual fields correlate better than visual acuity to severity of diabetic retinopathy

COMPARISON OF PROJECTION-RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-BASED METRICS FOR THE EARLY DETECTION OF RETINAL MICROVASCULAR IMPAIRMENTS IN DIABETES MELLITUS.

Abnormalities of retinal function in type 2 diabetes mellitus patients without clinical diabetic retinopathy detected by multifocal electroretinogram

Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features

Towards Optimal Filtering of "standard" Multifocal Electroretinogram (mferg) Recordings: Findings in Normal and Diabetic Subjects.

Retinal Vasculature–function Correlation in Non-Proliferative Diabetic Retinopathy